+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antipsychotic Drug"

From
Antipsychotic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antipsychotic Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 193 Pages
  • Global
From
Antipsychotic Drugs Market Report 2024 - Product Thumbnail Image

Antipsychotic Drugs Market Report 2024

  • Report
  • November 2024
  • 175 Pages
  • Global
From
From
From
From
From
Parkinson's disease psychosis - Pipeline Insight, 2024, - Product Thumbnail Image

Parkinson's disease psychosis - Pipeline Insight, 2024,

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cannabis-Induced Psychosis (CIP) - Pipeline Insight, 2024 - Product Thumbnail Image

Cannabis-Induced Psychosis (CIP) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth. The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more